Trial site
East Coast Institute for Research, LLC
- 6running trials
- 11closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes6 trials
- Obesity4 trials
- Chronic kidney disease2 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia2 trials
- Glaucoma2 trials
- Heart failure2 trials
- High blood pressure2 trials
- Type 1 diabetes2 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Graves' disease1 trial
- Peripheral artery disease1 trial
- and 2 more
- Phase
- Phase 312 trials
- Phase 24 trials
- Phase 41 trial
- Status
- Completed11 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company5 trials
- Boehringer Ingelheim2 trials
- Alcon Research1 trial
- Amgen1 trial
- Duke University1 trial
- and 7 more
Running trials
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Active, not recruiting
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Site data: ClinicalTrials.govUpdated 17 Nov 2026